一个分子更新和儿童低级结质瘤当前试验的审查

Sarah Al-Jilaihawi1, Stephen Lowis1

  • 1Department of Paediatric Oncology, Bristol Royal Hospital for Children, Bristol, UK.

Pediatric neurosurgery
|August 21, 2023
PubMed
概括

儿科低度结质瘤 (pLGGs) 需要新的治疗方法来持续控制和改善存活率. 分子分类和向疗法的进步,特别是RAS-mitogen-activated protein kinase (RAS/MAPK) 途径的进步,为这些儿童大脑瘤提供了新的希望.

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K